Suchergebnisse - "Weng, Tian-Hao"

PubPharm (22)

1

Host proteins interact with viral elements and affect the life cycle of highly pathogenic avian influenza A virus H7N9

enthalten in: Heliyon | 2024

von Yu, D. | Wu, X. | Weng, T. | +7

2

RON Receptor Tyrosine Kinase in Tumorigenic Stemness as a Therapeutic Target of Antibody-drug Conjugates for Eradication of Triple-negative Breast Cancer Stem Cells

enthalten in: Current cancer drug targets | 2023

von Suthe, S. | Yao, H. | Weng, T. | +1

3

Novel pathogenic characteristics of highly pathogenic avian influenza virus H7N9 : viraemia and extrapulmonary infection

enthalten in: Emerging microbes & infections | 2020

von Wu, X. | Zhao, L. | Tang, S. | +11

4

Highly pathogenic H7N9 avian influenza virus infection associated with up-regulation of PD-1/PD-Ls pathway-related molecules

enthalten in: International immunopharmacology | 2020

von Li, Y. | Hu, C. | Cheng, L. | +5

5

RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer

enthalten in: Cancer research and treatment | 2020

von Weng, T. | Yao, M. | Xu, X. | +8

6

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy

enthalten in: Journal for immunotherapy of cancer | 2019

von Tong, X. | Feng, L. | Suthe, S. | +6

7

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy

enthalten in: Journal for ImmunoTherapy of Cancer | 2019

von Tong, X. | Feng, L. | Suthe, S. | +6

8

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy

enthalten in: Journal for ImmunoTherapy of Cancer | 2019

von Tong, X. | Feng, L. | Suthe, S. | +6

9

Correction to : Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

enthalten in: Journal for immunotherapy of cancer | 2019

von Yao, H. | Feng, L. | Suthe, S. | +9

ErratumFor: J Immunother Cancer. 2019 Mar 14;7(1):75. - PMID 30871619

10

Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

enthalten in: Journal for ImmunoTherapy of Cancer | 2019

von Yao, H. | Feng, L. | Suthe, S. | +9